Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Canadian practice guidelines for surgical intra-abdominal infections.

Chow AW, Evans GA, Nathens AB, Ball CG, Hansen G, Harding GK, Kirkpatrick AW, Weiss K, Zhanel GG.

Can J Infect Dis Med Microbiol. 2010 Spring;21(1):11-37. No abstract available.

2.

Improved eradication of Clostridium difficile spores from toilets of hospitalized patients using an accelerated hydrogen peroxide as the cleaning agent.

Alfa MJ, Lo E, Wald A, Dueck C, DeGagne P, Harding GK.

BMC Infect Dis. 2010 Sep 15;10:268. doi: 10.1186/1471-2334-10-268.

3.

Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus.

Alfa MJ, Sepehri S, De Gagne P, Helawa M, Sandhu G, Harding GK.

J Clin Microbiol. 2010 Sep;48(9):3095-9. doi: 10.1128/JCM.00594-10. Epub 2010 Jun 30.

4.

Acanthamoeba species Keratitis in a Soft Contact Lens Wearer Molecularly Linked to Well Water.

Mubareka S, Alfa M, Harding GK, Booton G, Ekins M, Vancaeseele P.

Can J Infect Dis Med Microbiol. 2006 Mar;17(2):120-2.

5.

Reductions in workload and reporting time by use of methicillin-resistant Staphylococcus aureus screening with MRSASelect medium compared to mannitol-salt medium supplemented with oxacillin.

Lagacé-Wiens PR, Alfa MJ, Manickam K, Harding GK.

J Clin Microbiol. 2008 Apr;46(4):1174-7. doi: 10.1128/JCM.01253-07. Epub 2008 Jan 30.

6.

Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals.

Zhanel GG, Harding GK, Rosser S, Hoban DJ, Karlowsky JA, Alfa M, Kabani A, Embil J, Gin A, Williams T, Nicolle LE.

Can J Infect Dis. 2000 Jan;11(1):38-41.

7.

A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1.

Lagacé-Wiens PR, Harding GK.

CMAJ. 2007 Aug 28;177(5):451-3. No abstract available.

8.

A non-healing nodule in a returned traveller.

Lagacé-Wiens PR, Harding GK.

CMAJ. 2006 Mar 14;174(6):775-6. No abstract available.

9.

Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria.

Nicolle LE, Zhanel GG, Harding GK.

World J Urol. 2006 Feb;24(1):61-5. Epub 2005 Dec 31.

PMID:
16389540
10.

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ; NAUTICA Group.

Int J Antimicrob Agents. 2005 Nov;26(5):380-8.

PMID:
16243229
11.

Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.

Zelenitsky SA, Iacovides H, Ariano RE, Harding GK.

Diagn Microbiol Infect Dis. 2005 Jan;51(1):39-43.

PMID:
15629227
12.

Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia.

Ariano RE, Nyhlén A, Donnelly JP, Sitar DS, Harding GK, Zelenitsky SA.

Ann Pharmacother. 2005 Jan;39(1):32-8. Epub 2004 Dec 14.

PMID:
15598967
13.

Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.

Carrie AG, Metge CJ, Collins DM, Harding GK, Zhanel GG.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):863-70.

PMID:
15386718
14.

Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model.

Zelenitsky SA, Iacovides H, Harding GK, Ariano RE.

Diagn Microbiol Infect Dis. 2004 May;49(1):67-70.

PMID:
15135504
15.

Peritoneal fluid titer test for peritoneal dialysis-related peritonitis.

Strijack C, Harding GK, Ariano RE, Zelenitsky SA.

Antimicrob Agents Chemother. 2004 May;48(5):1719-26.

16.
17.

Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.

Zelenitsky SA, Harding GK, Sun S, Ubhi K, Ariano RE.

J Antimicrob Chemother. 2003 Oct;52(4):668-74. Epub 2003 Sep 1.

PMID:
12951354
18.

AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model.

Zelenitsky SA, Ariano RE, Iacovides H, Sun S, Harding GK.

J Antimicrob Chemother. 2003 Apr;51(4):905-11. Epub 2003 Mar 13.

PMID:
12654762
19.

Antimicrobial treatment in diabetic women with asymptomatic bacteriuria.

Harding GK, Zhanel GG, Nicolle LE, Cheang M; Manitoba Diabetes Urinary Tract Infection Study Group.

N Engl J Med. 2002 Nov 14;347(20):1576-83.

20.

Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.

Ariano RE, Franczuk C, Fine A, Harding GK, Zelenitsky SA.

Perit Dial Int. 2002 May-Jun;22(3):335-8.

PMID:
12227390
21.

Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy.

Zelenitsky SA, Ariano RE, Harding GK, Silverman RE.

Antimicrob Agents Chemother. 2002 Sep;46(9):3026-30.

22.

An outbreak of necrotizing enterocolitis associated with a novel clostridium species in a neonatal intensive care unit.

Alfa MJ, Robson D, Davi M, Bernard K, Van Caeseele P, Harding GK.

Clin Infect Dis. 2002 Sep 1;35(Suppl 1):S101-5.

PMID:
12173117
23.

The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C. difficile panel, EIA for Tox A/B and cytotoxin assays.

Alfa MJ, Swan B, VanDekerkhove B, Pang P, Harding GK.

Diagn Microbiol Infect Dis. 2002 Aug;43(4):257-63.

PMID:
12151184
24.

Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.

Gershon AS, de Azavedo JC, McGeer A, Ostrowska KI, Church D, Hoban DJ, Harding GK, Weiss K, Abbott L, Smaill F, Gourdeau M, Murray G, Low DE; Canadian Bacterial Surveillance Network.

Antimicrob Agents Chemother. 2002 May;46(5):1553-6.

26.

Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea.

Alfa MJ, Kabani A, Lyerly D, Moncrief S, Neville LM, Al-Barrak A, Harding GK, Dyck B, Olekson K, Embil JM.

J Clin Microbiol. 2000 Jul;38(7):2706-14.

28.

Assessment of the FAN anaerobic bottle for culture of continuous ambulatory peritoneal dialysis fluid using the BacT/Alert system.

Van Caeseele P, Alfaa MJ, Harding GK.

Diagn Microbiol Infect Dis. 2000 Feb;36(2):85-90.

PMID:
10705048
29.

Biopsy forceps as a source of bacterial contamination leading to overgrowth of Helicobacter pylori culture medium with Pseudomonas aeruginosa.

Cooper CL, Alfa MJ, Harding GK.

Infect Control Hosp Epidemiol. 1999 May;20(5):300-1. No abstract available.

PMID:
10349941
30.

E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.

Rosser SJ, Alfa MJ, Hoban S, Kennedy J, Harding GK.

J Clin Microbiol. 1999 Jan;37(1):26-30.

31.

Screening pregnant women for group B streptococcal colonization.

Madani TA, Harding GK, Helewa M, Alfa MJ.

Infection. 1998 Sep-Oct;26(5):288-91.

PMID:
9795786
32.

Urinary antibody level and survival in bacteriuric institutionalized older subjects.

Nicolle LE, Duckworth H, Brunka J, Urias B, Kennedy J, Murray D, Harding GK.

J Am Geriatr Soc. 1998 Aug;46(8):947-53.

PMID:
9706881
33.

Isolation of toxigenic Clostridium difficile from dialysate fluid in a fatal case of chronic ambulatory peritoneal dialysis-related peritonitis.

Laroche MC, Alfa MJ, Harding GK.

Clin Infect Dis. 1997 Nov;25(5):1248. No abstract available.

PMID:
9402394
34.

Complicated urinary tract infections.

Ronald AR, Harding GK.

Infect Dis Clin North Am. 1997 Sep;11(3):583-92.

PMID:
9378924
35.
36.

Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly.

Orr PH, Peeling RW, Fast M, Brunka J, Duckworth H, Harding GK, Nicolle LE.

Clin Infect Dis. 1996 Dec;23(6):1240-5.

PMID:
8953065
37.

Photo quiz. Symmetric peripheral gangrene.

Embil JM, Light RB, Harding GK.

Clin Infect Dis. 1996 Dec;23(6):1233, 1311. No abstract available.

PMID:
8953063
38.
39.

Febrile urinary infection in the institutionalized elderly.

Orr PH, Nicolle LE, Duckworth H, Brunka J, Kennedy J, Murray D, Harding GK.

Am J Med. 1996 Jan;100(1):71-7.

PMID:
8579090
40.

Mycobacterium abscessus infection of a Norplant contraceptive implant site.

Alfa MJ, Sisler JJ, Harding GK.

CMAJ. 1995 Nov 1;153(9):1293-6.

42.

Intraabdominal infection: a review.

McClean KL, Sheehan GJ, Harding GK.

Clin Infect Dis. 1994 Jul;19(1):100-16. Review.

PMID:
7948510
43.

The management of urinary infections: what have we learned in the past decade?

Harding GK, Ronald AR.

Int J Antimicrob Agents. 1994 Jun;4(2):83-8.

PMID:
18611593
44.

Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole.

Nicolle LE, Louie TJ, Dubois J, Martel A, Harding GK, Sinave CP.

Antimicrob Agents Chemother. 1994 Jun;38(6):1368-73.

45.

Prospective study of decubitus ulcers in two long term care facilities.

Nicolle LE, Orr P, Duckworth H, Brunka J, Kennedy J, Urias B, Murray D, Harding GK.

Can J Infect Control. 1994 Summer;9(2):35-8.

PMID:
8000069
46.

Gross hematuria in residents of long-term-care facilities.

Nicolle LE, Orr P, Duckworth H, Brunka J, Kennedy J, Murray D, Harding GK.

Am J Med. 1993 Jun;94(6):611-8.

PMID:
8506887
47.

Urinary immunoreactive interleukin-1 alpha and interleukin-6 in bacteriuric institutionalized elderly subjects.

Nicolle LE, Brunka J, Orr P, Wilkins J, Harding GK.

J Urol. 1993 May;149(5):1049-53.

PMID:
8483207
48.

Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin.

Nicolle LE, DuBois J, Martel AY, Harding GK, Shafran SD, Conly JM.

Antimicrob Agents Chemother. 1993 Mar;37(3):574-9.

49.

Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Zhanel GG, Hoban DJ, Harding GK.

Can J Infect Dis. 1992 Jul;3(4):193-201.

50.

Comparative activity of daptomycin and teicoplanin against enterococci isolated from blood and urine.

Forward KR, Degagne P, Bartlett KR, Harding GK.

Can J Infect Dis. 1992 Jul;3(4):173-8.

Supplemental Content

Loading ...
Support Center